NFKB1 and pachyonychia congenita: To evaluate the effect of the antimitoic drugs 2ME2 and Doc on NF-κB activity in human PC cells, we used androgen-dependent LNCaP and castration-resistant LN-AI, DU145, and PC3 cells.